Gen AI: A game changer for biopharma operations
Gen AI has become a hot topic among leaders at most big companies, more than two-thirds of which intend to increase their investments in the technology over the next three years. McKinsey has estimated the opportunity for gen AI in biopharmaceutical operations at $4 billion to $7 billion annually through workload and cost reductions, productivity…